News Releases

A nurse stands in a clinical space and prepares proton therapy.

Penn Medicine at the 2024 ASTRO Annual Meeting

September 27, 2024

Penn researchers will present clinical trial results, new data on FLASH radiation therapy, updates on expanding global access to radiation therapy, and more at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Cancer

Julia Borrelli to chair ACC Director's Leadership Council

September 09, 2024

Julia “Julie” Borrelli has been appointed chair of the Abramson Cancer Center Director's Leadership Council, succeeding Richard S. Schiffrin, Esq, who served as chair for five years. Borelli’s appointment becomes effective in November 2024.

Cancer

Combo immunotherapy makes waves of cancer-fighting T cells

August 29, 2024

A new tool for monitoring immune health patterns over time reveals how a pair of checkpoint inhibitor therapies works together to recruit new cancer-fighting T cells with every infusion.

Cancer

Carl June points to a computer screen in a lab.

Penn Medicine and Parker Institute renew alliance

August 21, 2024

The University of Pennsylvania and the Parker Institute for Cancer Immunotherapy have renewed their collaboration to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center.

Cancer

Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy

July 19, 2024

In a study published today in Science Immunology, Penn Medicine researchers identify CD5 as an immune checkpoint protein and a potential target of future cancer therapies.

Cancer

Neha Vapiwala, MD, named president-elect of ASTRO

July 18, 2024

Neha Vapiwala, MD, has been named president-elect of American Society for Radiation Oncology (ASTRO).

Cancer

Potential new strategy for advanced lung cancer

June 21, 2024

Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a small clinical trial led by investigators at the Abramson Cancer Center.

Cancer

The “armored” huCART19-IL18 is an anti-CD19 CAR that was further modified to secrete the pro-inflammatory cytokine, interleukin 18 (IL 18).

ASCO: New ‘Armored’ CAR produces significant responses

June 01, 2024

A new “armored” form of CAR T cell therapy may be able to help patients with non-Hodgkin lymphoma whose cancers do not respond to currently available CAR T cell therapies. The Phase I clinical trial was presented at the 2024 ASCO Annual Meeting.

Cancer

A woman receives a mammogram with a nurse standing next to her.

Penn Medicine Brings Free Cancer Screenings Back to West Philly

May 28, 2024

Penn Medicine will once again join with community partners and Siemens Healthineers to host a free mammogram clinic and community health fair, giving the local community convenient access to health screenings right in their neighborhood.

Cancer

A graphic of a blue background, displaying the text "Penn Medicine at the ASCO Annual Meeting."

Penn Medicine at the 2024 ASCO Annual Meeting

May 23, 2024

Researchers from the Abramson Cancer Center and Perelman School of Medicine will present data on the latest advances in clinical cancer research at the 2024 ASCO Annual Meeting, helmed by ASCO President Lynn Schuchter, MD.

Cancer

Browse By:

Penn Medicine at the 2024 ASTRO Annual Meeting

September 27, 2024

Julia Borrelli to chair ACC Director's Leadership Council

September 09, 2024

Combo immunotherapy makes waves of cancer-fighting T cells

August 29, 2024

Penn Medicine and Parker Institute renew alliance

August 21, 2024

Knockout of CD5 on CAR T Cells Boosts Anti-Tumor Efficacy

July 19, 2024

Neha Vapiwala, MD, named president-elect of ASTRO

July 18, 2024

Potential new strategy for advanced lung cancer

June 21, 2024

ASCO: New ‘Armored’ CAR produces significant responses

June 01, 2024

Penn Medicine Brings Free Cancer Screenings Back to West Philly

May 28, 2024

Penn Medicine at the 2024 ASCO Annual Meeting

May 23, 2024

Contacts